First Manhattan
TDOC icon

First Manhattan’s Teladoc Health TDOC Stock Holding History

First Manhattan’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-184
Closed -$2.78K – 1251
2024
Q1 		$2.78K Sell
184
-82
-31% -$1.49K ﹤0.01% 1259
2023
Q4 		$5.73K Hold
266
– – ﹤0.01% 1181
2023
Q3 		$4.94K Hold
266
– – ﹤0.01% 1237
2023
Q2 		$6.74K Hold
266
– – ﹤0.01% 1192
2023
Q1 		$6.89K Hold
266
– – ﹤0.01% 1253
2022
Q4 		$6.29K Hold
266
– – ﹤0.01% 1337
2022
Q3 		$6K Buy
266
+80
+43% +$2.81K ﹤0.01% 1294
2022
Q2 		$6K Hold
186
– – ﹤0.01% 1317
2022
Q1 		$13K Sell
186
-234
-56% -$16.9K ﹤0.01% 1236
2021
Q4 		$38K Sell
420
-955
-69% -$114K ﹤0.01% 1039
2021
Q3 		$174K Buy
1,375
+34
+3% +$4.95K ﹤0.01% 764
2021
Q2 		$222K Buy
1,341
+65
+5% +$10.5K ﹤0.01% 721
2021
Q1 		$231K Sell
1,276
-70
-5% -$16.2K ﹤0.01% 683
2020
Q4 		$269K Buy
1,346
+950
+240% +$193K ﹤0.01% 609
2020
Q3 		$86K Buy
396
+326
+466% +$69K ﹤0.01% 790
2020
Q2 		$13K Buy
+70
New +$12.3K ﹤0.01% 1125

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

First Manhattan's TDOC Position: Q2 2024 in Review

First Manhattan sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 184 shares — an estimated $2.78K sold.

First Manhattan first reported a position in TDOC in Q2 2020 and held it in 16 quarters. The position peaked at $269K in Q4 2020. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • First Manhattan reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 184 Teladoc Health shares in Q2 2024, an estimated $2.78K.
  • First Manhattan first reported a position in Teladoc Health in Q2 2020 and held it in 16 quarters.
  • First Manhattan's Teladoc Health position peaked at $269K in Q4 2020.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.